Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Neuronetics, Inc. (STIM)
|
Add to portfolio |
|
|
|
| Price: |
$4.28
| | Metrics |
| OS: |
28.9
|
M
| |
-69
|
% ROE
|
| Market cap: |
$124
|
M
| |
-78
|
% ROIC
|
|
Net cash:
|
$9.19
|
M
| |
$0.32
|
per share
|
|
EV:
|
$114
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($30.4)
|
M
| |
|
|
|
EBIT
|
($32.4)
|
M
| |
|
|
| EPS |
($1.14)
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 |
| Revenues | 65.2 | 55.3 | 49.2 | 62.7 | 52.8 | 40.4 | 34.2 |
| Revenue growth | 17.9% | 12.3% | -21.4% | 18.7% | 30.5% | 18.1% | |
| Cost of goods sold | 15.5 | 11.7 | 11.6 | 15.4 | 12.4 | 9.6 | 6.6 |
| Gross profit | 49.7 | 43.7 | 37.7 | 47.3 | 40.3 | 30.8 | 27.6 |
| Gross margin | 76.3% | 78.9% | 76.5% | 75.4% | 76.4% | 76.2% | 80.7% |
| Sales and marketing | 50.0 | 37.7 | 32.6 | 43.0 | 38.3 | 27.9 | 21.8 |
| Research and development | 9.3 | 7.9 | 9.2 | 13.7 | 8.2 | 7.9 | 8.2 |
| General and administrative | 25.5 | 25.6 | 18.2 | 17.5 | 13.7 | 8.6 | 6.9 |
| EBIT | -35.1 | -27.6 | -22.3 | -26.9 | -19.8 | -13.6 | -9.3 |
| EBIT margin | -53.8% | -49.8% | -45.3% | -43.0% | -37.6% | -33.7% | -27.3% |
| Pre-tax income | -37.2 | -31.2 | -27.5 | -29.0 | -24.1 | -16.1 | -11.2 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.3% | |
| Net income | -37.2 | -31.2 | -27.5 | -29.0 | -24.1 | -16.1 | -11.2 |
| Net margin | -57.0% | -56.4% | -55.8% | -46.3% | -45.7% | -39.7% | -32.8% |
| |
| Diluted EPS | ($1.38) | ($1.22) | ($1.46) | ($1.58) | ($2.69) | ($86.34) | ($76.95) |
| Shares outstanding (diluted) | 26.9 | 25.5 | 18.8 | 18.4 | 8.9 | 0.2 | 0.1 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|